Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-01-26

Clinical Trial Update: Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating renal denervation for resistant hypertension in patients with end-stage renal disease; the trial status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renal denervation

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Hypertension | Phase 3 | Status: UNKNOWN